Core Viewpoint - The company, Tibet Lizhongyuan Biotechnology Co., Ltd., is modernizing traditional Tibetan medicine through advanced technology and global perspectives, as part of Kunming Pharmaceutical Group's strategic layout [1] Group 1: Technological Empowerment - The company has established a leading Tibetan medicine research and development center in Lhasa Economic and Technological Development Zone, utilizing cutting-edge technologies such as supercritical extraction and nano-formulations to uncover the active ingredients of high-altitude medicinal materials like Rhodiola and Cordyceps [2] - The traditional Tibetan medicine preparation process "Zuo Tai" has been standardized, leading to the development of products targeting bone and joint diseases and immune regulation, revitalizing ancient Tibetan medicine [2] - The proprietary "Tibetan Medicine Compound Intelligent Matching System" has been patented, integrating the wisdom of the "Four Medical Classics" with digital technology [2] Group 2: Quality Assurance and Market Expansion - The company emphasizes quality as its lifeline, adhering to the principle of "origin is the way," establishing GAP-certified planting bases at altitudes above 4,000 meters to control the quality of medicinal materials from the source [3] - Through the "Tibetan Medicine + Health" strategy, the company has launched lightweight products such as health teas and medicinal skincare products, successfully entering the young consumer market [3] - As of 2024, the core product "Snow Domain Bone Treasure" series has achieved a market share of 12% in the national orthopedic medication market, becoming one of the top three recommended products by doctors, showcasing the company's strong market influence and consumer trust [3]